006-b203901

A look at the day ahead in European and global markets Audio Articles now available! Download the Reuters App.   Morning Bid Europe Morning Bid Europe A look at the day ahead in European and global markets By Stella Qiu, Australia Economics & Markets Correspondent     Data refreshes every time you open this email. For more European market news, click here . Please send any feedback to morningbid@thomsonreuters.com . It is tariff deadline day and President Donald Trump delivered by  slapping fresh levies  on imports from dozens of countries, including those that do not have a trade deal yet. Rates were set at 35% for Canada, 25% for India, 20% for Taiwan and 19% for Thailand. Switzerland got a whopping 39% -- one of the steepest -- raising the question: what's Trump got against the Swiss? Not buying enough American...

And, low-grade prostate cancer is not always low-risk. Audio Articles now available! Download the Reuters App.   Health Rounds Health Rounds By Nancy Lapid , Health Science Editor Hello Health Rounds readers! Today we feature two potentially important discoveries for cancer patients. Researchers have found a link between consuming an artificial sweetener common in diet sodas and poorer outcomes in patients treated with immunotherapies, and a potential solution to the problem. We also highlight a study that found low-grade prostate cancers may warrant more aggressive treatment.  In U.S. breaking news , Trump pressures 17 pharma CEOs to cut drug prices ; Vaccination rates for measles, other diseases drop further ; EPA targets key health ruling underpinning greenhouse gas rules ; FDA's top vaccine official Vinay Prasad leaves agency after short stint ; and Su...